Related Experiment Videos
Nocturnal asthma, its pathogenesis and treatment
1University of Texas Health Science Center, School of Medicine, Department of Internal Medicine, Houston.
Progress in Clinical and Biological Research
|January 1, 1990
Summary
Nocturnal asthma management involves understanding circadian rhythms. Daily inhaled beta-agonists, evening sustained-release theophylline, and rhythm-timed inhaled corticosteroids offer optimized treatment strategies.
Area of Science:
- Chronobiology
- Pulmonology
- Pharmacology
Background:
- Nocturnal asthma pathophysiology is linked to chronobiologic and environmental factors.
- Optimizing asthma medications requires understanding these cyclic processes.
- Circadian variations significantly impact asthma symptom severity and frequency.
Purpose of the Study:
- To elucidate the role of chronobiology in nocturnal asthma.
- To propose optimized therapeutic strategies for managing nocturnal asthma.
- To highlight the importance of timing in asthma medication efficacy.
Main Methods:
- Review of existing chronobiologic and environmental data related to asthma.
- Analysis of pharmacokinetic and pharmacodynamic profiles of asthma medications.
- Integration of chronotherapeutic principles into asthma management guidelines.
Main Results:
- Circadian rhythms influence airway inflammation and hyperresponsiveness.
- Specific medication timings can enhance therapeutic outcomes for nocturnal asthma.
- A combination of inhaled beta-agonists, sustained-release theophylline, and inhaled corticosteroids, when timed appropriately, can effectively manage symptoms.
Conclusions:
- Understanding circadian rhythms is crucial for effective nocturnal asthma management.
- Rhythm-based administration of inhaled beta-agonists, theophylline, and corticosteroids offers an optimized therapeutic approach.
- Chronotherapy represents a promising strategy to improve quality of life for nocturnal asthma patients.